Guiding a global biotech company through ATMP facility qualification
Guiding a global biotech company through ATMP facility qualification
Qualification & Validation
Pharma, ATMP
Share
\
\
X (Twitter)
\
\
LinkedIn
\
\
WhatsApp
\
\
Copy link
\
\
Mail
Bringing an ATMP production facility to operational status requires meticulous planning, regulatory compliance, and technical expertise. When a global biotechnology company set out to commission and qualify two new ATMP therapy production sites, they faced tight deadlines, complex validation processes, and a transition from paper-based to digital documentation.
QbD Group stepped in to provide strategic project planning, risk-based qualification, and quality-driven process improvements, ensuring the facilities met all necessary GMP standards and were fully prepared for clinical validation runs.
1
Challenge
2
Approach
3
Result
Challenge
Navigating complex ATMP facility commissioning
The project involved the commissioning and qualification of two advanced therapy medicinal product (ATMP) production sites. With overlapping timelines, the client needed to transition from paper-based to digital documentation.
Additionally, the limited experience with the cryogenic phase of production posed a significant challenge. A critical aspect was the qualification of 500 small-scale process and lab equipment within a tight timeframe to support process validation runs.
Approach
Strategic execution for compliance and efficiency
QbD Group provided expertise and structured execution to ensure the success of the project. The approach included:
- Overall project planning, follow-up, and issue management
- Risk-based qualification approach, ensuring regulatory compliance
- Quality-driven continuous improvement, including updated GMP-compliant templates
- Support for requalification and improvement activities after equipment release
Result
Achieving timely qualification and certification
Through QbD Group’s structured approach, all equipment was qualified and released on time, allowing the project to proceed smoothly. Additionally, the sites were successfully certified for clinical validation runs, ensuring compliance with industry standards and enabling the client to move forward with production.
.jpg?width=300&height=300&name=Guiding%20a%20global%20biotech%20company%20through%20ATMP%20facility%20qualification%20(3).jpg)

.jpg?width=1080&height=1080&name=Guiding%20a%20global%20biotech%20company%20through%20ATMP%20facility%20qualification%20(2).jpg)
Get in touch
Facing the complexities of ATMP facility commissioning and qualification?
Our experts can support you with strategic project planning, risk-based qualification, and quality-driven process improvements, ensuring your facilities meet GMP standards and are ready for clinical validation. Contact us today to discover how we can support your ATMP production site projects.
First name*
Last name*
Professional Email*
Company name*
Role*
Please SelectC-level / VPDirector(Sr.) ManagerSpecialist/AnalystIntern/ApprenticeIndividual contributorOther
Department*
Please SelectStrategy & ManagementRegulatory & VigilanceQuality Assurance & ControlIT & Digital InnovationManufacturing & ProductionProduct DevelopmentResearch & InnovationClinical Affairs & OperationsMedical AffairsMarket AccessSales & MarketingHRProcurementOther
Mobile phone number
Country*
Please SelectAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAsia/Pacific RegionAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCote d'IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaEuropeFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern and Antarctic LandsGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRéunionRomaniaRussiaRwandaSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe
Industry *
Please SelectMedical DevicesIn Vitro DiagnosticsPharmaBiotechAnimal HealthService providerConsumer HealthOther
Question submitted*
Field of Interest at time of last SRA
Content Title
Content Type
Content Division
QbD Group is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.
-
Yes, I agree to receive personalized newsletters with market insights, invitations for exclusive events and educational webinars from the QbD Group.
-
I consent to the privacy policy and understand that my personal data will be stored and processed *